T. Rowe Price Associates
AVAH icon

T. Rowe Price Associates’s Aveanna Healthcare AVAH Stock Holding History

T. Rowe Price Associates’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
65,065
+26,135
+67% +$184K ﹤0.01% 2574
2026
Q1 		$251K Sell
38,930
-19,332
-33% -$149K ﹤0.01% 2758
2025
Q4 		$477K Buy
58,262
+12,992
+29% +$117K ﹤0.01% 2418
2025
Q3 		$402K Hold
45,270
– – ﹤0.01% 2458
2025
Q2 		$237K Hold
45,270
– – ﹤0.01% 2634
2025
Q1 		$246K Sell
45,270
-8,429
-16% -$39.8K ﹤0.01% 2546
2024
Q4 		$246K Buy
53,699
+2,649
+5% +$13.6K ﹤0.01% 2600
2024
Q3 		$266K Sell
51,050
-28,151
-36% -$127K ﹤0.01% 2530
2024
Q2 		$219K Buy
79,201
+5,140
+7% +$12.8K ﹤0.01% 2559
2024
Q1 		$185K Buy
74,061
+503
+0.7% +$1.21K ﹤0.01% 2643
2023
Q4 		$198K Sell
73,558
-12,000
-14% -$22.9K ﹤0.01% 2548
2023
Q3 		$102K Buy
85,558
+3,640
+4% +$5.64K ﹤0.01% 2666
2023
Q2 		$139K Buy
81,918
+22,400
+38% +$28.1K ﹤0.01% 2625
2023
Q1 		$62K Hold
59,518
– – ﹤0.01% 2758
2022
Q4 		$46K Hold
59,518
– – ﹤0.01% 2821
2022
Q3 		$90K Buy
59,518
+21,000
+55% +$43.2K ﹤0.01% 2748
2022
Q2 		$87K Buy
38,518
+11,886
+45% +$34.5K ﹤0.01% 2781
2022
Q1 		$91K Buy
26,632
+1,000
+4% +$5.43K ﹤0.01% 2865
2021
Q4 		$190K Buy
+25,632
New +$186K ﹤0.01% 2771

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates's AVAH Position: Q2 2026 in Review

T. Rowe Price Associates increased its Aveanna Healthcare (AVAH) stake by 67% in Q2 2026, buying an estimated $184K and bringing the position to 65,065 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

T. Rowe Price Associates first reported a position in AVAH in Q4 2021 and has held it in 19 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • T. Rowe Price Associates held 65,065 shares of Aveanna Healthcare worth $558K as of Q2 2026.
  • T. Rowe Price Associates bought 26,135 Aveanna Healthcare shares in Q2 2026, an estimated $184K.
  • Aveanna Healthcare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2574 holding.
  • T. Rowe Price Associates first reported a position in Aveanna Healthcare in Q4 2021 and has held it in 19 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.